After penetration into the lower airways, bacterial lipopolysaccharide (LPS) interacts with alveolar cells in a fluid environment consisting of pulmonary surfactant, a lipid—protein complex which prevents alveolar collapsing and participates in lung defense. The two hydrophilic surfactant components SP-A and SP-D are proteins with collagen-like and lectin domains (collectins) able to interact with carbohydrate-containing ligands present on microbial membranes, and with defined regions of LPS. This explains their capacity to damage the bacterial envelope and induce an antimicrobial effect. In addition, they modulate LPS-induced production of pro-inflammatory mediators in leukocytes by interaction with LPS or with leukocyte receptors. A third surfactant component, SP-C, is a small, highly hydrophobic lipopeptide which interacts with lipid A and reduces LPS-induced effects in macrophages and splenocyte cultures. The interaction of the different SPs with CD14 might explain their ability to modulate some LPS responses. Although the alveolar fluid contains other antiLPS and antimicrobial agents, SPs are the most abundant proteins which might contribute to protect the lung epithelium and reduce the incidence of LPS-induced lung injury. The presence of the surfactant collectins SP-A and SP-D in non-pulmonary tissues, such as the female genital tract, extends their field of action to other mucosal surfaces.
Holmskov U., Thiel S., Jensenius JCCollectins and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol2003; 21: 547—578.
2.
Curstedt T., Johansson J., Persson P. et al. Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. Proc Natl Acad Sci USA1990; 87: 2985—2989.
3.
Brogden KA, Cutlip RC, Lehmkuhl HDComplexing of bacterial lipopolysaccharide with lung surfactant. Infect Immun1986; 52: 644—649.
4.
Fehrenbach H. , Brasch F., Uhlig S.et al.Early alterations in intracellular and alveolar surfactant of the rat lung in response to endotoxin. Am J Respir Crit Care Med1998; 157: 1630—1639.
5.
Crouch E., Wright JRSurfactant proteins A and D and pulmonary host defense. Annu Rev Physiol2001; 63: 521—554.
6.
Gardai SJ, Xiao YQ, Dickinson M.et al.By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell2003; 115: 13—23.
7.
Chroneos ZC, Abdolrasulnia R., Whitsett JA, Rice WR, Shepherd VLPurification of a cell-surface receptor for surfactant protein A. J Biol Chem1996; 271: 16375—16383.
8.
Tino MJ, Wright JRGlycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner. Am J Respir Cell Mol Biol1999; 20: 759—768.
9.
Sano H., Chiba H., Iwaki D., Sohma H., Voelker DR, Kuroki Y.Surfactant proteins A and D bind CD14 by different mechanisms. J Biol Chem2000; 275: 22442—22451.
10.
Murakami S. , Iwaki D., Mitsuzawa H. et al. Surfactant protein A inhibits peptidoglycan-induced tumor necrosis factor-alpha secretion in U937 cells and alveolar macrophages by direct interaction with Toll-like receptor 2. J Biol Chem2002; 277: 6830—6837.
11.
Girard R., Pedron T., Uematsu S. et al. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J Cell Sci2003; 116: 293—302.
12.
Van Iwaarden JF, Pikaar JC, Storm J. et al. Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides. Biochem J1994; 303: 407—411.
13.
Kuan SF, Rust K., Crouch E.Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage . J Clin Invest1992; 90: 97—106.
14.
DeSilva NS, Ofek I., Crouch ECInteractions of surfactant protein D with fatty acids. Am J Respir Cell Mol Biol2003; 29: 757—770.
15.
Wu H., Kuzmenko A., Wan S. et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest2003; 111: 1589—1602.
16.
Garcia-Verdugo I., Wang G., Floros J., Casals C.Structural analysis and lipid-binding properties of recombinant human surfactant protein A derived from one or both genes. Biochemistry2002; 41: 14041—-14053.
17.
Head JF, Mealy TR, McCormack FX, Seaton BACrystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A. J Biol Chem2003; 278: 43254—43260.
18.
Shrive AK, Tharia HA, Strong P. et al. High-resolution structural insights into ligand binding and immune cell recognition by human lung surfactant protein D. J Mol Biol2003; 331: 509—523.
19.
Arias-Diaz J., Garcia-Verdugo I., Casals C., Sanchez-Rico N., Vara E., Balibrea JLEffect of surfactant protein A (SP-A) on the production of cytokines by human pulmonary macrophages . Shock2000; 14: 300—306.
20.
Borron P., McIntosh JC, Korfhagen TR, Whitsett JA, Taylor J., Wright JRSurfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol2000; 278: L840—L847.
21.
Bufler P., Schmidt B., Schikor D., Bauernfeind A., Crouch EC, Griese M.Surfactant protein A and D differently regulate the immune response to non-mucoid Pseudomonas aeruginosa and its lipopolysaccharide. Am J Respir Cell Mol Biol2003; 28: 249—256.
22.
Chroneos Z. , Shepherd VLDifferential regulation of the mannose and SP-A receptors on macrophages. Am J Physiol1995; 269: L721—L726.
23.
McIntosh JC , Swyers AH, Fisher JH, Wright JRSurfactant proteins A and D increase in response to intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol1996; 15: 509—519.
24.
Beers MF, Hamvas A., Moxley MA et al. Pulmonary surfactant metabolism in infants lacking surfactant protein B. Am J Respir Cell Mol Biol2000; 22: 380—391.
25.
Augusto L., Le Blay K., Auger G., Blanot D., Chaby R.Interaction of bacterial lipopolysaccharide with mouse surfactant protein C inserted into lipid vesicles. Am J Physiol2001; 281: L776—L785.
26.
Augusto LA, Li J., Synguelakis M., Johansson J., Chaby R.Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J Biol Chem2002; 277: 23484—23492.
27.
Li J., Ikegami M., Na CL et al. N-terminally extended surfactant protein (SP) C isolated from SP-B-deficient children has reduced surface activity and inhibited lipopolysaccharide binding. Biochemistry2004; 43: 3891—3898.
28.
Augusto LA, Synguelakis M., Espinassous Q., Lepoivre M., Johansson J., Chaby R.Cellular antiendotoxin activities of lung surfactant protein C in lipid vesicles . Am J Respir Crit Care Med2003; 168: 335—341.
29.
Augusto LA, Synguelakis M., Johansson J., Pedron T., Girard R., Chaby R.Interaction of pulmonary surfactant protein C with CD14 and lipopolysaccharide . Infect Immun2003; 71: 61—67.
30.
Leth-Larsen R., Floridon C., Nielsen O., Holmskov U.Surfactant protein D in the female genital tract. Mol Hum Reprod2004; 10: 149—154.
31.
Condon JC, Jeyasuria P., Faust JM, Mendelson CRSurfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc Natl Acad Sci USA2004; 101: 4978—4983.
